ATAI Life Sciences NV (ATAI)
1.71
+0.19
(+12.50%)
USD |
NASDAQ |
Nov 22, 12:04
ATAI Life Sciences Shareholders Equity (Quarterly): 145.72M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 145.72M |
| June 30, 2024 | 167.89M |
| March 31, 2024 | 222.54M |
| December 31, 2023 | 242.96M |
| September 30, 2023 | 266.28M |
| June 30, 2023 | 212.55M |
| March 31, 2023 | 236.82M |
| December 31, 2022 | 260.74M |
| Date | Value |
|---|---|
| September 30, 2022 | 289.40M |
| June 30, 2022 | 311.68M |
| March 31, 2022 | 346.01M |
| December 31, 2021 | 376.91M |
| September 30, 2021 | 453.19M |
| June 30, 2021 | 474.85M |
| March 31, 2021 | 111.39M |
| December 31, 2020 | 90.82M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
90.82M
Minimum
Dec 2020
474.85M
Maximum
Jun 2021
263.11M
Average
251.85M
Median
Shareholders Equity (Quarterly) Benchmarks
| Affimed NV | 19.21M |
| InflaRx NV | 72.91M |
| BioNTech SE | 21.35B |
| Immatics NV | 427.24M |
| CureVac NV | 809.41M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 197.52M |
| Total Liabilities (Quarterly) | 51.20M |
| Debt to Equity Ratio | 0.1561 |
| Current Ratio | 5.807 |
| Net Debt Paydown Yield | -0.77% |